603127 昭衍新药
已收盘 07-01 15:00:00
资讯
新帖
简况
6月29日昭衍新药涨6.80%，易方达医疗保健行业混合A基金重仓该股
证券之星 · 06-29 16:32
6月29日昭衍新药涨6.80%，易方达医疗保健行业混合A基金重仓该股
昭衍新药：公司目前暂未有回购A股股份的计划
证券之星 · 06-29 15:37
昭衍新药：公司目前暂未有回购A股股份的计划
港股医药股走强 昭衍新药涨超8%
每日经济新闻 · 06-29 10:26
港股医药股走强 昭衍新药涨超8%
医药外包概念走强 昭衍新药(06127)涨9.16% 机构指相关标的业绩有望超预期
金吾财讯 · 06-29 10:20
医药外包概念走强 昭衍新药(06127)涨9.16% 机构指相关标的业绩有望超预期
昭衍新药（603127）披露调整2026年A股限制性股票激励计划授予价格公告，6月23日股价下跌0.38%
证券之星 · 06-23
昭衍新药（603127）披露调整2026年A股限制性股票激励计划授予价格公告，6月23日股价下跌0.38%
6月22日昭衍新药发布公告，股东减持2248.02万股
证券之星 · 06-22
6月22日昭衍新药发布公告，股东减持2248.02万股
昭衍新药(06127)：股东顾晓磊、顾美芳分别减持1506.18万股、741.84万股 减持计划实施完毕
智通财经 · 06-22
昭衍新药(06127)：股东顾晓磊、顾美芳分别减持1506.18万股、741.84万股 减持计划实施完毕
6月18日昭衍新药涨9.99%，易方达医疗保健行业混合A基金重仓该股
证券之星 · 06-18
6月18日昭衍新药涨9.99%，易方达医疗保健行业混合A基金重仓该股
异动快报：昭衍新药（603127）6月18日11点9分触及涨停板
证券之星 · 06-18
异动快报：昭衍新药（603127）6月18日11点9分触及涨停板
医药外包概念回暖 昭衍新药(06127)涨4.47%、药明康德(02359)涨3.35%
金吾财讯 · 06-18
医药外包概念回暖 昭衍新药(06127)涨4.47%、药明康德(02359)涨3.35%
股市必读：昭衍新药（603127）6月16日董秘有最新回复
证券之星 · 06-17
股市必读：昭衍新药（603127）6月16日董秘有最新回复
每周股票复盘：昭衍新药（603127）两日大宗交易超1.97亿元
证券之星 · 06-14
每周股票复盘：昭衍新药（603127）两日大宗交易超1.97亿元
6月9日昭衍新药发生1笔大宗交易 成交金额1.28亿元
证券之星 · 06-09
6月9日昭衍新药发生1笔大宗交易 成交金额1.28亿元
昭衍新药与中国科学院昆明动物研究所签署战略合作协议
第一财经 · 06-05
昭衍新药与中国科学院昆明动物研究所签署战略合作协议
昭衍新药授予316万股限制性股票 激励对象280人
财中社 · 06-05
昭衍新药授予316万股限制性股票 激励对象280人
昭衍新药(06127)将于8月4日派发末期现金股息每股0.13786港元
智通财经 · 06-04
昭衍新药(06127)将于8月4日派发末期现金股息每股0.13786港元
昭衍新药(06127)：周冯源获委任为非执行董事
智通财经 · 06-04
昭衍新药(06127)：周冯源获委任为非执行董事
每周股票复盘：昭衍新药（603127）一周发生2笔大宗交易成交1.52亿
证券之星 · 05-31
每周股票复盘：昭衍新药（603127）一周发生2笔大宗交易成交1.52亿
5月21日昭衍新药现10笔大宗交易 机构净买入735.93万元
证券之星 · 05-21
5月21日昭衍新药现10笔大宗交易 机构净买入735.93万元
5月21日昭衍新药创60日新高，易方达医疗保健行业混合A基金重仓该股
证券之星 · 05-21
5月21日昭衍新药创60日新高，易方达医疗保健行业混合A基金重仓该股
加载更多
公司概况
公司名称：
北京昭衍新药研究中心股份有限公司
所属行业：
研究和试验发展
上市日期：
2017-08-25
主营业务：
北京昭衍新药研究中心股份有限公司的主营业务是以药物非临床安全性评价服务为主的药物临床前研究服务和实验动物及附属产品的销售业务。公司的主要产品是。公司同时具备中国NMPA、美国FDA、经合组织OECD、韩国MFDS、日本PMDA等GLP资质；2025年9月公司北京及太仓设施通过了OECD的GLP现场检查及复查。
发行价格：
12.51
{"stockData":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":40.94,"timestamp":1782889201000,"preClose":38.22,"halted":0,"volume":44626808,"delay":0,"changeRate":0.0712,"floatShares":630000000,"shares":749000000,"eps":0.6607,"marketStatus":"已收盘","change":2.72,"latestTime":"07-01 15:00:00","open":37.58,"high":41.37,"low":36.84,"amount":1753000000,"amplitude":0.1185,"askPrice":40.94,"askSize":1692,"bidPrice":40.93,"bidSize":26,"shortable":0,"etf":0,"ttmEps":0.6607,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782955800000},"marketStatusCode":5,"adr":0,"adjPreClose":38.22,"symbolType":"stock","openAndCloseTimeList":[[1782869400000,1782876600000],[1782882000000,1782889200000]],"highLimit":42.04,"lowLimit":34.4,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":749348220,"isCdr":false,"pbRate":3.59,"roa":"--","peRate":61.964583,"roe":"2.82%","epsLYR":0.4,"committee":-0.798469,"marketValue":30678000000,"turnoverRate":0.0708,"status":0,"hkstockBrief":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":18.59,"timestamp":1782806887007,"preClose":19.5,"halted":0,"volume":4826382,"delay":0,"premium":"-60.66"},"floatMarketCap":25807000000},"requestUrl":"/m/hq/s/603127","defaultTab":"news","newsList":[{"id":"2647121324","title":"6月29日昭衍新药涨6.80%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647121324","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647121324?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:32","pubTimestamp":1782721945,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日昭衍新药涨6.80%，收盘报39.6元，换手率6.58%，成交量41.46万手，成交额16.23亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共44家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","BK1141","06127","BK1576","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647003329","title":"昭衍新药：公司目前暂未有回购A股股份的计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2647003329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647003329?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:37","pubTimestamp":1782718671,"startTime":"0","endTime":"0","summary":"证券之星消息，昭衍新药(603127)06月29日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，现阶段同行业各家公司都在回购股票，公司是否有计划回购股票，请直接回答有或者没有。昭衍新药回复：您好！公司目前暂未有回购A股股份的计划，如有，会按照相关规定履行信息披露义务。公司曾于2024年披露了关于A股股份回购的计划并于2025年实施完成，具体请查阅公司披露的相关公告。感谢关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900017730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399300","BK1576","BK1141","159982","603127","06127","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647475973","title":"港股医药股走强 昭衍新药涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647475973","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647475973?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:26","pubTimestamp":1782699986,"startTime":"0","endTime":"0","summary":"6月29日，截至发稿，昭衍新药(06127.HK)涨8.55%，凯莱英(06821.HK)涨7.64%，康龙化成(03759.HK)涨7.51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606293786079564.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606293786079564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159718","06127","BK1576","603127","BK0216","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647034208","title":"医药外包概念走强 昭衍新药(06127)涨9.16% 机构指相关标的业绩有望超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2647034208","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647034208?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:20","pubTimestamp":1782699626,"startTime":"0","endTime":"0","summary":"消息面上，东吴证券研究指，22家CXO上市公司2026Q1实现收入、归母净利润、扣非归母净利润总额增速分别同比增长18.6%、21.9%、63.5%，业绩逐季度改善。根据医药魔方，2026Q1，国内创新药一级市场融资总金额25.9亿美元，同比上涨128.6%，2026Q1中国相关交易数量及金额涨势迅猛，总金额达614亿美元，大幅领先国外交易总金额。该机构认为，随着中国创新药在全球研发创新中的比重提升，与其配套的CXO产业链将进一步增强。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984678","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","LU3063872942.SGD","01548","603127","06127","LU0359202008.SGD","LU0823426308.USD","LU0052750758.USD","BK0216","LU0348825331.USD","HK0000306685.HKD","BK1576","LU1046422090.SGD","BK1583","LU0320764599.SGD","LU2242644610.SGD","LU0043850808.USD","LU0140636845.USD","HK0000306701.USD","159938","09939","LU0326950275.SGD","LU0348767384.USD","LU0588546209.SGD","LU2045819591.USD","LU0348735423.USD","LU0708995583.HKD","LU1794554557.SGD","BK1161","LU2125910500.SGD","02359","LU1720050803.USD","LU0456846285.SGD","LU0417516738.SGD","LU1242518931.SGD","LU1688375341.USD","LU0181495838.USD","BK1141","LU0979878070.USD","BK1574","HK0000320223.HKD","03347","HK0000320264.USD","06821","BK1191","02269","LU0348766576.USD","LU0417516902.SGD","LU1880383366.USD","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645325718","title":"昭衍新药（603127）披露调整2026年A股限制性股票激励计划授予价格公告，6月23日股价下跌0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645325718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645325718?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:16","pubTimestamp":1782224182,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘，昭衍新药报收于36.53元，较前一交易日下跌0.38%，最新总市值为273.74亿元。该股当日开盘36.66元，最高38.28元，最低36.03元，成交额达12.23亿元，换手率为5.21%。近日，北京昭衍新药研究中心股份有限公司召开第五届董事会第五次会议，审议通过了《关于调整2026年A股限制性股票激励计划授予价格的议案》。本次调整已获股东会授权，无需提交股东会审议。董事会薪酬与考核委员会及律师均认为调整程序合法合规，未损害公司及股东利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300042456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0216","603127","06127","BK1141","399300","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645602593","title":"6月22日昭衍新药发布公告，股东减持2248.02万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645602593","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645602593?lang=zh_cn&edition=full","pubTime":"2026-06-22 18:01","pubTimestamp":1782122474,"startTime":"0","endTime":"0","summary":"证券之星消息，6月22日昭衍新药发布公告《昭衍新药:昭衍新药股东减持A股股份结果公告》，其股东顾美芳、顾晓磊于2026年4月7日至2026年6月18日间合计减持2248.02万股，占公司目前总股本的3.0%，变动期间该股股价下跌2.57%，截止6月18日收盘报35.66元。股东增减持详情见下表：根据昭衍新药2026年一季报公布的十大股东详情如下：本文数据来源于昭衍新药公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200027429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK0216","BK1576","BK1141","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645235360","title":"昭衍新药(06127)：股东顾晓磊、顾美芳分别减持1506.18万股、741.84万股 减持计划实施完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2645235360","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645235360?lang=zh_cn&edition=full","pubTime":"2026-06-22 17:37","pubTimestamp":1782121057,"startTime":"0","endTime":"0","summary":"顾晓磊及其一致行动人顾美芳合计减持不超过公司总股本的3.00%。截至2026年6月18日，顾晓磊、顾美芳分别减持1506.18万股、741.84万股，减持计划实施完毕。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK0216","06127","BK1576","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644057237","title":"6月18日昭衍新药涨9.99%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644057237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644057237?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:32","pubTimestamp":1781771578,"startTime":"0","endTime":"0","summary":"证券之星消息，6月18日昭衍新药涨9.99%，收盘报35.66元，换手率4.38%，成交量27.59万手，成交额9.52亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共44家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800028604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK1576","603127","06127","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644779578","title":"异动快报：昭衍新药（603127）6月18日11点9分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2644779578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644779578?lang=zh_cn&edition=full","pubTime":"2026-06-18 11:15","pubTimestamp":1781752533,"startTime":"0","endTime":"0","summary":"证券之星6月18日盘中消息，11点9分昭衍新药（603127）触及涨停板。其所属行业医疗服务目前上涨。领涨股为皓元医药。该股为CAR-T疗法，创新药，基因编辑概念热股，当日CAR-T疗法概念上涨2.55%，创新药概念上涨2.45%，基因编辑概念上涨2.42%。6月17日的资金流向数据方面，主力资金净流出3896.52万元，占总成交额8.92%，游资资金净流入240.98万元，占总成交额0.55%，散户资金净流入3655.55万元，占总成交额8.37%。近5日资金流向一览见下表：昭衍新药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800015892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK0216","BK1141","BK1576","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644307776","title":"医药外包概念回暖 昭衍新药(06127)涨4.47%、药明康德(02359)涨3.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644307776","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644307776?lang=zh_cn&edition=full","pubTime":"2026-06-18 10:15","pubTimestamp":1781748909,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医药外包概念回暖，截至发稿，昭衍新药 涨4.47%，药明康德涨3.35%，药明生物涨2.75%，金斯瑞生物科技涨2.31%，凯莱英涨1.24%，康龙化成涨1.06%。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984065","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127","LU0348767384.USD","02359","LU0327786744.USD","LU2045819591.USD","LU0572944931.SGD","01548","BK1521","LU1242518931.SGD","IE00B5MMRT66.SGD","BK1141","LU0348735423.USD","603259","LU1979443071.USD","LU0307460666.USD","LU1251922891.USD","LU1303224171.USD","603127","BK1515","LU2495084118.USD","LU0456846285.SGD","LU0516422366.SGD","159938","IE00BPRC5H50.USD","LU0051755006.USD","LU0588546209.SGD","LU0516422440.USD","BK1161","LU1997245094.SGD","LU0326950275.SGD","09939","LU0979878070.USD","LU1997244956.HKD","SG9999002562.SGD","BK1574","IE00B543WZ88.USD","03759","LU1688375341.USD","LU0516422952.EUR","LU0140636845.USD","SG9999002463.SGD","02269","IE00B0JY6N72.USD","LU2488822045.USD","LU0823426480.USD","BK1589","LU0359201612.USD","LU0359202008.SGD","LU1046422090.SGD","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644761086","title":"股市必读：昭衍新药（603127）6月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644761086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644761086?lang=zh_cn&edition=full","pubTime":"2026-06-17 01:40","pubTimestamp":1781631620,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，昭衍新药报收于32.38元，下跌1.1%，换手率2.42%，成交量15.28万手，成交额4.93亿元。董秘最新回复投资者： 您好，公司在建安评基地有哪些董秘： 您好！公司正在建设的安评基地主要是在广州。当日关注点交易信息汇总：6月16日主力资金净流出2165.81万元，占总成交额0.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700000634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","603127","BK1141","BK0216","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643217925","title":"每周股票复盘：昭衍新药（603127）两日大宗交易超1.97亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643217925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643217925?lang=zh_cn&edition=full","pubTime":"2026-06-14 01:20","pubTimestamp":1781371224,"startTime":"0","endTime":"0","summary":"截至2026年6月12日收盘，昭衍新药报收于32.52元，较上周的32.6元下跌0.25%。本周，昭衍新药6月12日盘中最高价报32.93元。6月9日盘中最低价报30.7元。昭衍新药当前最新总市值243.69亿元，在医疗服务板块市值排名7/51，在两市A股市值排名861/5206。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061400000206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK0216","BK1576","06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642200466","title":"6月9日昭衍新药发生1笔大宗交易 成交金额1.28亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642200466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642200466?lang=zh_cn&edition=full","pubTime":"2026-06-09 17:48","pubTimestamp":1780998517,"startTime":"0","endTime":"0","summary":"证券之星消息，6月9日昭衍新药发生大宗交易，交易数据如下：大宗交易成交价格29.8元，相对当日收盘价折价5.19%，成交429万股，成交金额12784.2万元，买方营业部为中信证券股份有限公司江苏分公司，卖方营业部为华泰证券股份有限公司太仓太平南路证券营业部。近三个月该股共发生13笔大宗交易，合计成交12.66万手，折价成交13笔。截至2026年6月9日收盘，昭衍新药报收于31.43元，上涨0.19%，换手率2.12%，成交量13.34万手，成交额4.16亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900029235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","BK1576","BK0216","BK1141","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641191007","title":"昭衍新药与中国科学院昆明动物研究所签署战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2641191007","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641191007?lang=zh_cn&edition=full","pubTime":"2026-06-05 11:30","pubTimestamp":1780630244,"startTime":"0","endTime":"0","summary":"近日，北京昭衍新药研究中心股份有限公司与中国科学院昆明动物研究所举行战略合作座谈会暨签约仪式，双方正式签署战略合作框架协议，围绕实验动物资源高值利用、重大疾病动物模型开发、数字生物医药、创新药研发与成果转化等领域开启全面、深度、长期合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606053761716532.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606053761716532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["603127","BK1141","BK1576","BK0216","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641919514","title":"昭衍新药授予316万股限制性股票 激励对象280人","url":"https://stock-news.laohu8.com/highlight/detail?id=2641919514","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641919514?lang=zh_cn&edition=full","pubTime":"2026-06-05 08:46","pubTimestamp":1780620360,"startTime":"0","endTime":"0","summary":"6月4日，昭衍新药（603127/06127）发布公告，公司授予激励对象316万股A股限制性股票，授予价格为19.17元/股，激励对象人数为280人。2026年一季度，昭衍新药实现收入3.16亿元，归母净利润2.38亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606053761037769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","603127","BK1141","BK0216","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640716304","title":"昭衍新药(06127)将于8月4日派发末期现金股息每股0.13786港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640716304","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640716304?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:37","pubTimestamp":1780583844,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布公告，将于2026年8月4日派发截至2025年12月31日止年度的末期现金股息每股0.13786港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","603127","BK1141","BK1576","BK0216","06127","EWH","VIG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640163089","title":"昭衍新药(06127)：周冯源获委任为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2640163089","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640163089?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:31","pubTimestamp":1780583488,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布公告，有关委任周冯源先生为非执行董事的决议案已获股东于年度股东会上通过。周先生的任期自年度股东会之日起，并于第五届董事会届满时终止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450432.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06127","BK1141","BK1576","603127","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639601946","title":"每周股票复盘：昭衍新药（603127）一周发生2笔大宗交易成交1.52亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2639601946","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639601946?lang=zh_cn&edition=full","pubTime":"2026-05-31 01:38","pubTimestamp":1780162693,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，昭衍新药（603127）报收于35.17元，较上周的41.35元下跌14.95%。本周，昭衍新药5月25日盘中最高价报42.99元。5月27日盘中最低价报34.4元。昭衍新药当前最新总市值263.55亿元，在医疗服务板块市值排名7/51，在两市A股市值排名810/5207。本周关注点来自交易信息汇总：5月27日昭衍新药发生2笔大宗交易，成交金额1.52亿元交易信息汇总5月27日昭衍新药发生2笔大宗交易，成交金额1.52亿元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK1576","603127","BK0216","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637381642","title":"5月21日昭衍新药现10笔大宗交易 机构净买入735.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637381642","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637381642?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:48","pubTimestamp":1779356918,"startTime":"0","endTime":"0","summary":"证券之星消息，5月21日昭衍新药发生大宗交易，交易数据如下：近三个月该股共发生10笔大宗交易，合计成交4.02万手，折价成交10笔。该股近期无解禁股上市。截至2026年5月21日收盘，昭衍新药报收于42.77元，上涨10.01%，涨停，换手率9.63%，成交量60.71万手，成交额25.52亿元。该股近半年内有股东持股变动，合计净减持487.53万股，股东增减持明细如下表：该股最近90天内共有8家机构给出评级，买入评级7家，增持评级1家；过去90天内机构目标均价为44.32。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100033117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK1576","BK1141","BK0216","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637740383","title":"5月21日昭衍新药创60日新高，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637740383","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637740383?lang=zh_cn&edition=full","pubTime":"2026-05-21 16:27","pubTimestamp":1779352067,"startTime":"0","endTime":"0","summary":"证券之星消息，5月21日昭衍新药涨10.01%创60日新高，收盘报42.77元，换手率9.63%，成交量60.71万手，成交额25.52亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共44家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为32.51亿元，最新净值3.742，较上一交易日上涨0.38%，近一年上涨6.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100030309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","BK1141","BK0216","06127","BK1576"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782932552748,"stockEarnings":[{"period":"1week","weight":0.0783},{"period":"1month","weight":0.2236},{"period":"3month","weight":0.1266},{"period":"6month","weight":0.1729},{"period":"1year","weight":0.8431},{"period":"ytd","weight":0.1729}],"compareEarnings":[{"period":"1week","weight":0.0004},{"period":"1month","weight":0.0135},{"period":"3month","weight":0.0493},{"period":"6month","weight":0.0362},{"period":"1year","weight":0.1893},{"period":"ytd","weight":0.0362}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京昭衍新药研究中心股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2017-08-25","address":"北京市大兴区北京经济技术开发区荣京东街甲5号","registeredCapital":"74934万元","survey":" 北京昭衍新药研究中心股份有限公司的主营业务是以药物非临床安全性评价服务为主的药物临床前研究服务和实验动物及附属产品的销售业务。公司的主要产品是。公司同时具备中国NMPA、美国FDA、经合组织OECD、韩国MFDS、日本PMDA等GLP资质；2025年9月公司北京及太仓设施通过了OECD的GLP现场检查及复查。","listedPrice":12.51},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(603127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,603127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(603127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}